scholarly journals Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease

2019 ◽  
Vol 25 (12) ◽  
pp. 1990-1995 ◽  
Author(s):  
Kristen Alley ◽  
Anand Singla ◽  
Anita Afzali
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Emergency Services ◽  
Prescription Opioid ◽  
Opioid Use ◽  
Inflammatory Bowel ◽  
Resultant Increase ◽  
Use Of Emergency Services ◽  
Prescription Opioid Use ◽  
Care Costs

Using Truven Health MarketScan Databases, we examined prescription opioid use in patients with inflammatory bowel disease (IBD) and the resultant increase in use of emergency services and rise in healthcare costs among these patients.

One-year risk of opioid use disorder after index hospitalization for inflammatory bowel disease

2020 ◽  
Vol 35 (11) ◽  
pp. 2081-2087
Author(s):  
Mishal Reja ◽  
Nitya Hajela ◽  
Michael Makar ◽  
Daniel Marino ◽  
Abhishek Bhurwal ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Opioid Use Disorder ◽  
Index Hospitalization ◽  
Opioid Use ◽  
Inflammatory Bowel ◽  
One Year

Advocating for Patients With Inflammatory Bowel Disease: How to Navigate the Prior Authorization Process

2019 ◽  
Vol 25 (10) ◽  
pp. 1621-1628 ◽  
Author(s):  
Shubha Bhat ◽  
Toni Zahorian ◽  
Regine Robert ◽  
Francis A Farraye
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Prior Authorization ◽  
Treatment Pathways ◽  
Treatment Delays ◽  
Manage Health Care ◽  
Inflammatory Bowel ◽  
Step Therapy ◽  
Care Costs

Abstract In an effort to manage health care costs and avoid improper medication use, prior authorizations (PAs) have become a standard stipulation required by payers in the determination of medication coverage. For gastroenterologists managing patients, especially those with inflammatory bowel disease (IBD), the PA process is time-consuming and further complicated by 2 additional factors: step therapy requirements and failure of payers to recognize updated IBD treatment pathways. These factors often lead to PA denials and cause treatment delays, which in turn can lead to disease progression, ongoing patient suffering, and ultimately an increase in both direct and indirect total costs. In this manuscript, the PA process, PA models, tips and available resources to navigate the PA process, and future advocacy efforts are discussed with the intent to help gastroenterology practices optimize PA outcomes and improve the care provided to patients with IBD and other gastrointestinal disorders.

scholarly journals Vitamin D Status in Veterans With Inflammatory Bowel Disease: Relationship to Health Care Costs and Services

2011 ◽  
Vol 176 (6) ◽  
pp. 711-714 ◽  
Author(s):  
Antwan Atia ◽  
Ravindra Murthy ◽  
Beth A. Bailey ◽  
Todd Manning ◽  
Linda L. Garrett ◽  
...  
Keyword(s):  
Health Care ◽  
Inflammatory Bowel Disease ◽  
Vitamin D ◽  
Health Care Costs ◽  
Bowel Disease ◽  
Vitamin D Status ◽  
Inflammatory Bowel ◽  
Care Costs

scholarly journals Rate of Adverse Events and Associated Health Care Costs for the Management of Inflammatory Bowel Disease in Germany

2020 ◽  
Vol 42 (1) ◽  
pp. 130-143.e3 ◽  
Author(s):  
Thomas Wilke ◽  
Antje Groth ◽  
Gráinne H. Long ◽  
Amanda R. Tatro ◽  
Diana Sun
Keyword(s):  
Health Care ◽  
Inflammatory Bowel Disease ◽  
Adverse Events ◽  
Health Care Costs ◽  
Bowel Disease ◽  
Inflammatory Bowel ◽  
Care Costs

scholarly journals The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease

2018 ◽  
Vol 24 (7) ◽  
pp. 1380-1388 ◽  
Author(s):  
Alyce Anderson ◽  
Benjamin Click ◽  
Claudia Ramos-Rivers ◽  
Ioannis E Koutroubakis ◽  
Jana G Hashash ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Poor Quality ◽  
Opioid Use ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document